Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

NCT05273827 · clinicaltrials.gov ↗

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Immunotherapy
Analgesia
NSCLC
Delirium

Interventions

DRUG: neoadjuvant immunotherapy
DRUG: Neoadjuvant chemotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]
[object Object]